More Products

Cardiovascular Ablation

A Class II passive and sterile medical device for improved safety and effectiveness during cardiac intervention surgeries.

TechBank Medical has engaged the leading cardiovascular hospital in China to guide the product development effort, resulting in the development of strong, independent intellectual property rights, with world-wide protection.

Prototype development is complete, with clinical trials projected to reach completion by 2019. TechBank Medical will launch this product at the end of 2019 and will immediately start improving health care outcomes for those patients enduring cardiovascular ablation procedures.


A Class II active medical device using innovative,non-invasive oral care technologies for pain-free treatment of periodontal disease and increased oral health.

TechBank Medical established a joint venture with a U.S. start-up company and will lead the market introduction and sales expansion of the product throughout China.

Prototype development is complete. Clinical trials demonstrating superior clinical outcomes of the Oraflow device are projected to reach completion early in 2019, with a market launch at the end of 2019.

13/F, 1518 Minsheng Road, Jin Ying Plaza, Tower B, Shanghai 200135, P.R. China +86 (21) 2028 3600
55 Rongyang Road, Songjiang District, Shanghai 201613, P.R. China +86 (21) 2028 3600
R&D center and Manufacturing facility

Scan the mobile version